Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BLTE compared with GMAB: revenue, margins and what each company keeps, and the suppliers and customers both name
BLTE
Belite Bio, Inc
Change
Mkt cap
Revenue
Revenue
GMAB
Genmab A/S
Change
Mkt cap
Revenue
Revenue
vs
Compare
BLTE
Belite Bio, Inc
vs
GMAB
Genmab A/S
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
BLTE
No earnings history for BLTE.
GMAB
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Nov 5 '26
±7.5%
▼
−4.32%
×0.57
= implied
BLTE realized, solid
GMAB realized, hatched
One scale, both sides: full bar = 8%
× = |realized| ÷ implied
Source: market data
BLTE
Belite Bio, Inc
Change
154.51
▲
+7.91%
· post 154.51
Mkt cap
$6.1B
GMAB
Genmab A/S
Change
53.63
▲
+1.69%
· post 53.63
Closed
Nov 6 '26
Mkt cap
$34.5B
vs
Compare
Closed
Nov 6 '26
BLTE
Belite Bio, Inc
vs
GMAB
Genmab A/S
154.51
▲
+7.91%
post 154.51
Price
53.63
▲
+1.69%
post 53.63
$6.1B
Mkt cap
$34.5B
Change
Change
BLTE
154.51
▲
+7.91%
vs
GMAB
53.63
▲
+1.69%
Closed
Nov 6 '26